JPS02 Wednesday, 06/24/20 02:57:16 PM Re: StocksGoneWild post# 5272 Post # of 7084 In addition to the majority interest in Covid Clear, Ethema is buying: 1. The exclusive right to distribute the Covid Clear products in Canada on a royalty basis; and, 2. An exclusive right to sell to the addiction treatment industry in the United States on a commission basis. Ethema will be issuing $100,000 of restricted Ethema common stock for these rights. Source of 6/17/20 PR extracts: https://www.globenewswire.com/news-release/2020/06/17/2049699/0/en/Ethema-Signs-LOI-on-Acquisition-of-a-Majority-Interest-in-Biohazard-Health-Services-LLC.html - Yes, I did see that SGW. Based on the 6/17/20 PR, I think GRST may potentially be building quite the diversified revenue base with Covid Clear to not only diversify its revenue sources with royalties and commissions, but also ensure that patients feel safe coming into the addiction treatment centers by ensuring that they are properly sanitized. Go GRST! Buy cautiously and sell reluctantly. All of my posts are In My Opinion only based on the DD I have completed. Please do your own DD and make your own decisions.